Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH. The group will develop new technologies, advanced clinicalapplications,
Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH.
The group will develop new technologies, advanced clinicalapplications, and hardware and software enhancements, accordingto Sheldon Schaffer, HMSA vice president of marketing. Researchwill involve superconducting and permanent magnet technologies.
The company will recruit five engineers to staff the new facility,which will complement Hitachi's existing R&D operations inJapan.
HMSA, a joint venture between Hitachi and Summit World Trade,sells Hitachi MRI systems in the U.S.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.